Argus Research Reiterates Buy Rating on Cardinal Health, Inc. (CAH)

Market Context

Cardinal Health, Inc. operates in the Healthcare sector. The stock currently trades at $278.14 with a market capitalization of $47.1B. The stock has gained 36.7% over the past 52 weeks.

Analyst coverage from Argus Research provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Cardinal Health, Inc.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Cardinal Health, Inc.

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Nov 12, 2026	Argus Research	Buy	N/A
Nov 10, 2026	JP Morgan	Neutral	N/A
Nov 09, 2026	TD Cowen	Buy	N/A
Nov 06, 2026	RBC Capital	Outperform	N/A
Nov 06, 2026	Evercore ISI Group	Outperform	N/A

Related Tools: Analyst Ratings Dashboard | View CAH Stock Page